Evidence map›Paper›PMID 21284906›Full record

ReviewJournal of translational medicine2011

Coreceptor use in nonhuman primate models of HIV infection.

Silvana Tasca Sina, Wuze Ren, Cecilia Cheng-Mayer

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. In vivo evolution of env in SHIV-AD8Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. HIV-1-induced AIDS in monkeys.Science (New York, N.Y.) · 2014
    Article
  7. Article
  8. Review
  9. Review
  10. Nonhuman primate models for HIV/AIDS vaccine development.Current protocols in immunology · 2013
    Review
  11. Article
  12. Article
  13. The HIV-1 env protein: a coat of many colors.Current HIV/AIDS reports · 2012
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Silvana Tasca SinaAaron Diamond AIDS Research Center, 455 First Ave, 7th Floor, New York, New York, USA.
Wuze Ren
Cecilia Cheng-Mayer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SIV or SHIV infection of nonhuman primates (NHP) has been used to investigate the impact of coreceptor usage on the composition and dynamics of the CD4+ T cell compartment, mechanisms of disease induction and development of clinical syndrome. As the entire course of infection can be followed, with frequent access to tissue compartments, infection of rhesus macaques with CCR5-tropic SHIVs further allows for study of HIV-1 coreceptor switch after intravenous and mucosal inoculation, with longitudinal and systemic analysis to determine the timing, anatomical sites and cause for the change in envelope glycoprotein and coreceptor preference. Here, we review our current understanding of coreceptor use in NHPs and their impact on the pathobiological characteristics of the infection, and discuss recent advances in NHP studies to uncover the underlying selective pressures for the change in coreceptor preference in vivo.

Indexed as

AnimalsCD4-Positive T-LymphocytesCercocebus atysChlorocebus aethiopsDisease Models, Animalenv Gene Products, Human Immunodeficiency VirusHIV-1HumansImmune SystemMandrillusMiceMucous MembranePhenotypeReceptors, CCR5Receptors, CXCR4env Gene Products, Human Immunodeficiency VirusReceptors, CCR5Receptors, CXCR4

Identifiers

PMID21284906
PMCPMC3105507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.